Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

December 01, 1988; Volume 34,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Andrews, P R

    1. You have access
      Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
      D T Manallack, M G Wong, M Costa, P R Andrews and P M Beart
      Molecular Pharmacology December 1988, 34 (6) 863-879;

B

  1. Bean, A J

    1. You have access
      The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
      A J Bean, P D Shepard, B S Bunney, E J Nestler and R H Roth
      Molecular Pharmacology December 1988, 34 (6) 715-718;
  2. Beart, P M

    1. You have access
      Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
      D T Manallack, M G Wong, M Costa, P R Andrews and P M Beart
      Molecular Pharmacology December 1988, 34 (6) 863-879;
  3. Bockaert, J

    1. You have access
      A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
      A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
      Molecular Pharmacology December 1988, 34 (6) 880-887;
  4. Bouhelal, R

    1. You have access
      A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
      A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
      Molecular Pharmacology December 1988, 34 (6) 880-887;
  5. Bunney, B S

    1. You have access
      The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
      A J Bean, P D Shepard, B S Bunney, E J Nestler and R H Roth
      Molecular Pharmacology December 1988, 34 (6) 715-718;
  6. Burchell, B

    1. You have access
      The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes.
      M W Coughtrie, B Burchell, J E Leakey and R Hume
      Molecular Pharmacology December 1988, 34 (6) 729-735;
  7. Buyukbingol, E

    1. You have access
      An artificial intelligence approach to the study of the structural moieties relevant to drug-receptor interactions in aldose reductase inhibitors.
      G Klopman and E Buyukbingol
      Molecular Pharmacology December 1988, 34 (6) 852-862;

C

  1. Cory, R

    1. You have access
      A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
      A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
      Molecular Pharmacology December 1988, 34 (6) 880-887;
  2. Costa, M

    1. You have access
      Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
      D T Manallack, M G Wong, M Costa, P R Andrews and P M Beart
      Molecular Pharmacology December 1988, 34 (6) 863-879;
  3. Costa, T

    1. You have access
      Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
      T Costa, F J Klinz, L Vachon and A Herz
      Molecular Pharmacology December 1988, 34 (6) 744-754;
  4. Coughtrie, M W

    1. You have access
      The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes.
      M W Coughtrie, B Burchell, J E Leakey and R Hume
      Molecular Pharmacology December 1988, 34 (6) 729-735;

D

  1. Dumuis, A

    1. You have access
      A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
      A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
      Molecular Pharmacology December 1988, 34 (6) 880-887;

E

  1. Eng, W K

    1. You have access
      Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
      W K Eng, L Faucette, R K Johnson and R Sternglanz
      Molecular Pharmacology December 1988, 34 (6) 755-760;
  2. Evoniuk, G

    1. You have access
      Picrate and niflumate block anion modulation of radioligand binding to the gamma-aminobutyric acid/benzodiazepine receptor complex.
      G Evoniuk and P Skolnick
      Molecular Pharmacology December 1988, 34 (6) 837-842;

F

  1. Farb, D H

    1. You have access
      "Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylation.
      M Gyenes, M Farrant and D H Farb
      Molecular Pharmacology December 1988, 34 (6) 719-723;
  2. Farrant, M

    1. You have access
      "Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylation.
      M Gyenes, M Farrant and D H Farb
      Molecular Pharmacology December 1988, 34 (6) 719-723;
  3. Faucette, L

    1. You have access
      Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
      W K Eng, L Faucette, R K Johnson and R Sternglanz
      Molecular Pharmacology December 1988, 34 (6) 755-760;
  4. Forkert, P G

    1. You have access
      Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in murine liver: immunohistochemical localization with monoclonal antibodies.
      P G Forkert, P Mirehouse-Brown, S S Park and H V Gelboin
      Molecular Pharmacology December 1988, 34 (6) 736-743;

G

  1. Gelboin, H V

    1. You have access
      Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in murine liver: immunohistochemical localization with monoclonal antibodies.
      P G Forkert, P Mirehouse-Brown, S S Park and H V Gelboin
      Molecular Pharmacology December 1988, 34 (6) 736-743;
  2. Gommeren, W

    1. You have access
      The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
      P J Pauwels, W Gommeren, G Van Lommen, P A Janssen and J E Leysen
      Molecular Pharmacology December 1988, 34 (6) 843-851;
  3. Gyenes, M

    1. You have access
      "Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylation.
      M Gyenes, M Farrant and D H Farb
      Molecular Pharmacology December 1988, 34 (6) 719-723;

H

  1. Herz, A

    1. You have access
      Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
      T Costa, F J Klinz, L Vachon and A Herz
      Molecular Pharmacology December 1988, 34 (6) 744-754;
  2. Highet, R J

    1. You have access
      Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution.
      S S Lau, B A Hill, R J Highet and T J Monks
      Molecular Pharmacology December 1988, 34 (6) 829-836;
  3. Hill, B A

    1. You have access
      Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution.
      S S Lau, B A Hill, R J Highet and T J Monks
      Molecular Pharmacology December 1988, 34 (6) 829-836;
  4. Hokin, L E

    1. You have access
      Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
      M Reichman, W Nen and L E Hokin
      Molecular Pharmacology December 1988, 34 (6) 823-828;
  5. Hume, R

    1. You have access
      The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes.
      M W Coughtrie, B Burchell, J E Leakey and R Hume
      Molecular Pharmacology December 1988, 34 (6) 729-735;

J

  1. Jacobson, K A

    1. You have access
      High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.
      G L Stiles and K A Jacobson
      Molecular Pharmacology December 1988, 34 (6) 724-728;
  2. Jacquez, J A

    1. You have access
      Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor.
      W J Thomsen, J A Jacquez and R R Neubig
      Molecular Pharmacology December 1988, 34 (6) 814-822;
  3. Janssen, P A

    1. You have access
      The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
      P J Pauwels, W Gommeren, G Van Lommen, P A Janssen and J E Leysen
      Molecular Pharmacology December 1988, 34 (6) 843-851;
  4. Johnson, R K

    1. You have access
      Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
      W K Eng, L Faucette, R K Johnson and R Sternglanz
      Molecular Pharmacology December 1988, 34 (6) 755-760;

K

  1. Keen, M

    1. You have access
      Muscarinic acetylcholine receptors linked to the inhibition of adenylate cyclase activity in membranes from the rat striatum and myocardium can be distinguished on the basis of agonist efficacy.
      M Keen and S R Nahorski
      Molecular Pharmacology December 1988, 34 (6) 769-778;
  2. Klinz, F J

    1. You have access
      Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
      T Costa, F J Klinz, L Vachon and A Herz
      Molecular Pharmacology December 1988, 34 (6) 744-754;
  3. Klopman, G

    1. You have access
      An artificial intelligence approach to the study of the structural moieties relevant to drug-receptor interactions in aldose reductase inhibitors.
      G Klopman and E Buyukbingol
      Molecular Pharmacology December 1988, 34 (6) 852-862;

L

  1. Lau, S S

    1. You have access
      Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution.
      S S Lau, B A Hill, R J Highet and T J Monks
      Molecular Pharmacology December 1988, 34 (6) 829-836;
  2. Leakey, J E

    1. You have access
      The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes.
      M W Coughtrie, B Burchell, J E Leakey and R Hume
      Molecular Pharmacology December 1988, 34 (6) 729-735;
  3. Levine, L

    1. You have access
      Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism.
      L Levine
      Molecular Pharmacology December 1988, 34 (6) 793-799;
  4. Leysen, J E

    1. You have access
      The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
      P J Pauwels, W Gommeren, G Van Lommen, P A Janssen and J E Leysen
      Molecular Pharmacology December 1988, 34 (6) 843-851;

M

  1. Manallack, D T

    1. You have access
      Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
      D T Manallack, M G Wong, M Costa, P R Andrews and P M Beart
      Molecular Pharmacology December 1988, 34 (6) 863-879;
  2. Marvizón, J C

    1. You have access
      Anion regulation of [3H]strychnine binding to glycine-gated chloride channels is explained by the presence of two anion binding sites.
      J C Marvizón and P Skolnick
      Molecular Pharmacology December 1988, 34 (6) 806-813;
  3. Miller, R J

    1. You have access
      125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
      M W Walker and R J Miller
      Molecular Pharmacology December 1988, 34 (6) 779-792;
  4. Mirehouse-Brown, P

    1. You have access
      Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in murine liver: immunohistochemical localization with monoclonal antibodies.
      P G Forkert, P Mirehouse-Brown, S S Park and H V Gelboin
      Molecular Pharmacology December 1988, 34 (6) 736-743;
  5. Monks, T J

    1. You have access
      Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution.
      S S Lau, B A Hill, R J Highet and T J Monks
      Molecular Pharmacology December 1988, 34 (6) 829-836;

N

  1. Nahorski, S R

    1. You have access
      Muscarinic acetylcholine receptors linked to the inhibition of adenylate cyclase activity in membranes from the rat striatum and myocardium can be distinguished on the basis of agonist efficacy.
      M Keen and S R Nahorski
      Molecular Pharmacology December 1988, 34 (6) 769-778;
  2. Nen, W

    1. You have access
      Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
      M Reichman, W Nen and L E Hokin
      Molecular Pharmacology December 1988, 34 (6) 823-828;
  3. Nestler, E J

    1. You have access
      The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
      A J Bean, P D Shepard, B S Bunney, E J Nestler and R H Roth
      Molecular Pharmacology December 1988, 34 (6) 715-718;
  4. Neubig, R R

    1. You have access
      Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor.
      W J Thomsen, J A Jacquez and R R Neubig
      Molecular Pharmacology December 1988, 34 (6) 814-822;

P

  1. Park, S S

    1. You have access
      Distribution and induction sites of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in murine liver: immunohistochemical localization with monoclonal antibodies.
      P G Forkert, P Mirehouse-Brown, S S Park and H V Gelboin
      Molecular Pharmacology December 1988, 34 (6) 736-743;
  2. Pauwels, P J

    1. You have access
      The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
      P J Pauwels, W Gommeren, G Van Lommen, P A Janssen and J E Leysen
      Molecular Pharmacology December 1988, 34 (6) 843-851;

R

  1. Ramkumar, V

    1. You have access
      The new positive inotrope sulmazole inhibits the function of guanine nucleotide regulatory proteins by affecting GTP turnover.
      V Ramkumar and G L Stiles
      Molecular Pharmacology December 1988, 34 (6) 761-768;
  2. Reichman, M

    1. You have access
      Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
      M Reichman, W Nen and L E Hokin
      Molecular Pharmacology December 1988, 34 (6) 823-828;
  3. Roth, R H

    1. You have access
      The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
      A J Bean, P D Shepard, B S Bunney, E J Nestler and R H Roth
      Molecular Pharmacology December 1988, 34 (6) 715-718;

S

  1. Schmalzing, G

    1. You have access
      The role of a transmembrane pH gradient in uptake and release of imipramine and haloperidol in synaptosomes.
      G Schmalzing
      Molecular Pharmacology December 1988, 34 (6) 888-895;
  2. Sebben, M

    1. You have access
      A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
      A Dumuis, R Bouhelal, M Sebben, R Cory and J Bockaert
      Molecular Pharmacology December 1988, 34 (6) 880-887;
  3. Shepard, P D

    1. You have access
      The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
      A J Bean, P D Shepard, B S Bunney, E J Nestler and R H Roth
      Molecular Pharmacology December 1988, 34 (6) 715-718;
  4. Skolnick, P

    1. You have access
      Anion regulation of [3H]strychnine binding to glycine-gated chloride channels is explained by the presence of two anion binding sites.
      J C Marvizón and P Skolnick
      Molecular Pharmacology December 1988, 34 (6) 806-813;
    2. You have access
      Picrate and niflumate block anion modulation of radioligand binding to the gamma-aminobutyric acid/benzodiazepine receptor complex.
      G Evoniuk and P Skolnick
      Molecular Pharmacology December 1988, 34 (6) 837-842;
  5. Snyder, S H

    1. You have access
      Characterization of porphyrin interactions with peripheral type benzodiazepine receptors.
      A Verma and S H Snyder
      Molecular Pharmacology December 1988, 34 (6) 800-805;
  6. Sternglanz, R

    1. You have access
      Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
      W K Eng, L Faucette, R K Johnson and R Sternglanz
      Molecular Pharmacology December 1988, 34 (6) 755-760;
  7. Stiles, G L

    1. You have access
      High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.
      G L Stiles and K A Jacobson
      Molecular Pharmacology December 1988, 34 (6) 724-728;
    2. You have access
      The new positive inotrope sulmazole inhibits the function of guanine nucleotide regulatory proteins by affecting GTP turnover.
      V Ramkumar and G L Stiles
      Molecular Pharmacology December 1988, 34 (6) 761-768;

T

  1. Thomsen, W J

    1. You have access
      Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor.
      W J Thomsen, J A Jacquez and R R Neubig
      Molecular Pharmacology December 1988, 34 (6) 814-822;

V

  1. Vachon, L

    1. You have access
      Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
      T Costa, F J Klinz, L Vachon and A Herz
      Molecular Pharmacology December 1988, 34 (6) 744-754;
  2. Van Lommen, G

    1. You have access
      The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
      P J Pauwels, W Gommeren, G Van Lommen, P A Janssen and J E Leysen
      Molecular Pharmacology December 1988, 34 (6) 843-851;
  3. Verma, A

    1. You have access
      Characterization of porphyrin interactions with peripheral type benzodiazepine receptors.
      A Verma and S H Snyder
      Molecular Pharmacology December 1988, 34 (6) 800-805;

W

  1. Walker, M W

    1. You have access
      125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
      M W Walker and R J Miller
      Molecular Pharmacology December 1988, 34 (6) 779-792;
  2. Wong, M G

    1. You have access
      Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
      D T Manallack, M G Wong, M Costa, P R Andrews and P M Beart
      Molecular Pharmacology December 1988, 34 (6) 863-879;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 34, Issue 6
1 Dec 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics